$MDVX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in H-CYTE, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in H-CYTE, INC.. Get notifications about new insider transactions in H-CYTE, INC. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 29 2021 | MDVX | H-CYTE, INC. | Horne William E | Director | Option Exercise | J | 0.01 | 1,869,667 | 26,175 | 1,869,667 | |
Apr 29 2021 | MDVX | H-CYTE, INC. | Horne William E | Director | Option Exercise | J | 0.00 | 3,655,382 | 0 | 3,655,382 | |
Apr 12 2021 | MDVX | H-CYTE, INC. | Daniel Jeremy | Chief Financial Off ... | Option Exercise | A | 0.07 | 5,000,000 | 350,000 | 5,000,000 | |
Apr 08 2021 | MDVX | H-CYTE, INC. | WAGNER TODD R | 10% Owner | Option Exercise | J | 0.00 | 110,219,286 | 0 | 336,785,550 | |
Apr 08 2021 | MDVX | H-CYTE, INC. | WAGNER TODD R | 10% Owner | Option Exercise | J | 0.01 | 265,868,613 | 3,722,161 | 265,868,613 | |
Apr 08 2021 | MDVX | H-CYTE, INC. | WAGNER TODD R | 10% Owner | Option Exercise | J | 0.00 | 226,566,264 | 0 | 226,566,264 | |
Apr 05 2021 | MDVX | H-CYTE, INC. | Yurkowsky Michael | 10% Owner | Option Exercise | A | 0.07 | 3,500,000 | 245,000 | 3,500,000 | |
Apr 05 2021 | MDVX | H-CYTE, INC. | Monteleone Raymond | Director | Option Exercise | A | 0.07 | 3,000,000 | 210,000 | 3,000,000 | |
Apr 05 2021 | MDVX | H-CYTE, INC. | Horne William E | Director | Option Exercise | A | 0.07 | 2,000,000 | 140,000 | 2,000,000 | |
Apr 05 2021 | MDVX | H-CYTE, INC. | Greif Robert Smith | Chief Executive Off ... | Option Exercise | A | 0.07 | 34,000,000 | 2,380,000 | 34,000,000 | |
Mar 15 2021 | MDVX | H-CYTE, INC. | FARRIOR J REX III | 10% Owner | Option Exercise | J | 0.00 | 7,142,857 | 0 | 14,630,920 | |
Mar 15 2021 | MDVX | H-CYTE, INC. | FARRIOR J REX III | 10% Owner | Option Exercise | J | 0.01 | 7,488,063 | 104,833 | 7,488,063 | |
Mar 15 2021 | MDVX | H-CYTE, INC. | FARRIOR J REX III | 10% Owner | Option Exercise | J | 0.00 | 7,488,063 | 0 | 7,488,063 | |
Mar 15 2021 | MDVX | H-CYTE, INC. | FARRIOR J REX III | 10% Owner | Option Exercise | C | 0.41 | 15,518,111 | 6,334,493 | 0 | |
Mar 15 2021 | MDVX | H-CYTE, INC. | FARRIOR J REX III | 10% Owner | Buy | C | 0.41 | 15,518,111 | 6,334,493 | 15,518,111 | 0 to 15.5 M |
Jun 26 2020 | MDVX | H-CYTE, INC. | Horne William E | Chief Executive Off ... | Option Exercise | A | 0.00 | 4,368,278 | 0 | 4,368,278 | |
Jun 26 2020 | MDVX | H-CYTE, INC. | Horne William E | Chief Executive Off ... | Grant | A | 0.39 | 4,368,278 | 1,703,628 | 8,593,913 | 4.2 M to 8.6 M (+103.38 %) |
Jan 21 2020 | MDVX | H-CYTE, INC. | Yurkowsky Michael | Director | Buy | P | 0.15 | 10,000 | 1,450 | 1,531,207 | 1.5 M to 1.5 M (+0.66 %) |
Jan 21 2020 | MDVX | H-CYTE, INC. | Yurkowsky Michael | Director | Buy | P | 0.13 | 1,900 | 256 | 1,521,207 | 1.5 M to 1.5 M (+0.13 %) |
Jan 21 2020 | MDVX | H-CYTE, INC. | Yurkowsky Michael | Director | Buy | P | 0.14 | 5,000 | 675 | 1,519,307 | 1.5 M to 1.5 M (+0.33 %) |
Jan 21 2020 | MDVX | H-CYTE, INC. | Yurkowsky Michael | Director | Buy | P | 0.13 | 8,100 | 1,048 | 1,514,307 | 1.5 M to 1.5 M (+0.54 %) |
Dec 20 2019 | MDVX | H-CYTE, INC. | Yurkowsky Michael | Director | Buy | P | 0.11 | 7,500 | 825 | 1,506,207 | 1.5 M to 1.5 M (+0.50 %) |
Dec 20 2019 | MDVX | H-CYTE, INC. | Yurkowsky Michael | Director | Buy | P | 0.14 | 27,500 | 3,850 | 1,498,707 | 1.5 M to 1.5 M (+1.87 %) |
Sep 18 2019 | MDVX | H-CYTE, INC. | Horne William E | Chief Executive Off ... | Grant | A | 0.00 | 4,225,634 | 0 | 4,225,634 | 0 to 4.2 M |
Sep 18 2019 | MDVX | H-CYTE, INC. | Horne William E | Chief Executive Off ... | Option Exercise | A | 0.40 | 250,000 | 100,000 | 250,000 | |
Apr 29 2019 | MDVX | Medovex Corp. | Horne William B | Chief Executive Off ... | Grant | A | 0.00 | 4,225,634 | 0 | 4,225,634 | 0 to 4.2 M |
Apr 29 2019 | MDVX | Medovex Corp. | Horne William B | Chief Executive Off ... | Option Exercise | A | 0.40 | 250,000 | 100,000 | 250,000 | |
Jan 12 2018 | MDVX | Medovex Corp. | Crowne Jesse | Director | Grant | A | 0.55 | 10,407 | 5,724 | 210,747 | 200.3 K to 210.7 K (+5.19 %) |
Jan 05 2018 | MDVX | Medovex Corp. | Crowne Jesse | Director | Grant | A | 0.55 | 4,093 | 2,251 | 200,340 | 196.2 K to 200.3 K (+2.09 %) |
Jan 02 2018 | MDVX | Medovex Corp. | Betz Randal R | Director | Grant | A | 0.52 | 350 | 182 | 181,027 | 180.7 K to 181 K (+0.19 %) |
Jan 02 2018 | MDVX | Medovex Corp. | Betz Randal R | Director | Grant | A | 0.56 | 9,650 | 5,385 | 180,677 | 171 K to 180.7 K (+5.64 %) |
Dec 19 2017 | MDVX | Medovex Corp. | Thomas John C | Director | Sell | P | 0.70 | 6,000 | 4,200 | 115,960 | 122 K to 116 K (-4.92 %) |
Dec 19 2017 | MDVX | Medovex Corp. | Mogford Jon | Director | Sell | P | 0.70 | 1,000 | 700 | 16,840 | 17.8 K to 16.8 K (-5.61 %) |
Nov 01 2017 | MDVX | Medovex Corp. | GORLIN STEVE | Grant | A | 1.17 | 10,684 | 12,500 | 1,640,704 | 1.6 M to 1.6 M (+0.66 %) | |
Nov 01 2017 | MDVX | Medovex Corp. | Crowne Jesse | Director | Grant | A | 1.08 | 31,240 | 33,739 | 200,340 | 169.1 K to 200.3 K (+18.47 %) |
Nov 01 2017 | MDVX | Medovex Corp. | Crowne Jesse | Director | Grant | A | 1.17 | 2,137 | 2,500 | 169,100 | 167 K to 169.1 K (+1.28 %) |
Nov 01 2017 | MDVX | Medovex Corp. | Haufe Scott | Director | Grant | A | 1.17 | 12,821 | 15,001 | 1,031,782 | 1 M to 1 M (+1.26 %) |
Nov 01 2017 | MDVX | Medovex Corp. | Lawson James Ronald JR | Director | Grant | A | 1.17 | 12,821 | 15,001 | 18,256 | 5.4 K to 18.3 K (+235.90 %) |
Nov 01 2017 | MDVX | Medovex Corp. | Betz Randal R | Director | Grant | A | 1.17 | 12,821 | 15,001 | 164,837 | 152 K to 164.8 K (+8.43 %) |
Nov 01 2017 | MDVX | Medovex Corp. | Mogford Jon | Director | Grant | A | 1.17 | 12,821 | 15,001 | 15,840 | 3 K to 15.8 K (+424.68 %) |
Nov 01 2017 | MDVX | Medovex Corp. | PAPASAN LARRY W | Director | Grant | A | 1.17 | 12,821 | 15,001 | 228,136 | 215.3 K to 228.1 K (+5.95 %) |
Nov 01 2017 | MDVX | Medovex Corp. | Thomas John C | Director | Grant | A | 1.17 | 12,821 | 15,001 | 109,960 | 97.1 K to 110 K (+13.20 %) |
Nov 01 2017 | MDVX | Medovex Corp. | ANDREWS JAMES R M D | Director | Grant | A | 1.17 | 12,821 | 15,001 | 131,348 | 118.5 K to 131.3 K (+10.82 %) |
Nov 01 2017 | MDVX | Medovex Corp. | Hennies Clyde A. | Director | Grant | A | 1.17 | 12,821 | 15,001 | 131,348 | 118.5 K to 131.3 K (+10.82 %) |
Sep 21 2017 | MDVX | Medovex Corp. | Haufe Scott | Sell | S | 1.18 | 20,000 | 23,600 | 1,018,961 | 1 M to 1 M (-1.93 %) | |
Sep 21 2017 | MDVX | Medovex Corp. | Haufe Scott | Sell | S | 1.19 | 50,000 | 59,500 | 1,038,961 | 1.1 M to 1 M (-4.59 %) | |
Aug 22 2017 | MDVX | Medovex Corp. | GORLIN STEVE | Buy | P | 1.25 | 50,000 | 62,500 | 1,630,020 | 1.6 M to 1.6 M (+3.16 %) | |
Aug 16 2017 | MDVX | Medovex Corp. | GORLIN STEVE | Buy | P | 0.90 | 200,000 | 180,000 | 1,580,020 | 1.4 M to 1.6 M (+14.49 %) | |
Jul 18 2017 | MDVX | Medovex Corp. | Betz Randal R | Option Exercise | P | 1.15 | 5,495 | 6,319 | 5,495 | ||
Jul 18 2017 | MDVX | Medovex Corp. | Betz Randal R | Buy | P | 0.91 | 10,989 | 10,000 | 152,016 | 141 K to 152 K (+7.79 %) | |
Jun 29 2017 | MDVX | Medovex Corp. | GORLIN STEVE | Buy | P | 0.88 | 2,000 | 1,760 | 1,380,020 | 1.4 M to 1.4 M (+0.15 %) | |
Jun 29 2017 | MDVX | Medovex Corp. | GORLIN STEVE | Buy | P | 0.87 | 3,000 | 2,610 | 1,378,020 | 1.4 M to 1.4 M (+0.22 %) | |
Jun 20 2017 | MDVX | Medovex Corp. | Gorlin Jarrett S | CHIEF EXECUTIVE OFF ... | Buy | P | 0.90 | 20,000 | 18,000 | 662,172 | 642.2 K to 662.2 K (+3.11 %) |
Jun 15 2017 | MDVX | Medovex Corp. | GORLIN STEVE | Buy | P | 0.97 | 5,000 | 4,850 | 1,375,020 | 1.4 M to 1.4 M (+0.36 %) | |
Jun 08 2017 | MDVX | Medovex Corp. | GORLIN STEVE | Buy | P | 0.98 | 5,000 | 4,900 | 1,370,020 | 1.4 M to 1.4 M (+0.37 %) | |
Jun 08 2017 | MDVX | Medovex Corp. | GORLIN STEVE | Buy | P | 0.96 | 5,000 | 4,800 | 1,365,020 | 1.4 M to 1.4 M (+0.37 %) | |
Jun 08 2017 | MDVX | Medovex Corp. | GORLIN STEVE | Buy | P | 0.95 | 15,000 | 14,250 | 1,360,020 | 1.3 M to 1.4 M (+1.12 %) | |
Jun 08 2017 | MDVX | Medovex Corp. | GORLIN STEVE | Buy | P | 0.94 | 5,000 | 4,700 | 1,345,020 | 1.3 M to 1.3 M (+0.37 %) | |
Jun 07 2017 | MDVX | Medovex Corp. | Gorlin Jarrett S | CHIEF EXECUTIVE OFF ... | Buy | P | 0.94 | 5,000 | 4,700 | 642,172 | 637.2 K to 642.2 K (+0.78 %) |
Jun 07 2017 | MDVX | Medovex Corp. | Gorlin Jarrett S | CHIEF EXECUTIVE OFF ... | Buy | P | 0.92 | 5,000 | 4,600 | 637,172 | 632.2 K to 637.2 K (+0.79 %) |
Jun 07 2017 | MDVX | Medovex Corp. | Gorlin Jarrett S | CHIEF EXECUTIVE OFF ... | Buy | P | 0.91 | 5,000 | 4,550 | 632,172 | 627.2 K to 632.2 K (+0.80 %) |
Jun 07 2017 | MDVX | Medovex Corp. | Gorlin Jarrett S | CHIEF EXECUTIVE OFF ... | Buy | P | 0.90 | 5,000 | 4,500 | 627,172 | 622.2 K to 627.2 K (+0.80 %) |
Jun 07 2017 | MDVX | Medovex Corp. | Gorlin Jarrett S | CHIEF EXECUTIVE OFF ... | Buy | P | 0.89 | 5,000 | 4,450 | 622,172 | 617.2 K to 622.2 K (+0.81 %) |
Apr 18 2017 | MDVX | Medovex Corp. | Haufe Scott | Buy | P | 1.25 | 50,000 | 62,500 | 1,088,961 | 1 M to 1.1 M (+4.81 %) | |
Mar 30 2017 | MDVX | Medovex Corp. | Haufe Scott | Buy | P | 1.29 | 250,612 | 323,289 | 1,038,961 | 788.3 K to 1 M (+31.79 %) | |
Feb 27 2017 | MDVX | Medovex Corp. | Gorlin Jarrett S | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.13 | 48,142 | 54,400 | 48,142 | |
Feb 27 2017 | MDVX | Medovex Corp. | Sablowski Manfred | VP OF SALES AND MAR ... | Option Exercise | A | 1.13 | 26,549 | 30,000 | 26,549 | |
Feb 27 2017 | MDVX | Medovex Corp. | Kullmann Patrick C | COO, PRESIDENT | Option Exercise | A | 1.13 | 40,885 | 46,200 | 40,885 | |
Feb 27 2017 | MDVX | Medovex Corp. | Wright Jeffery Scott | CHIEF FINANCIAL OFF ... | Option Exercise | A | 1.13 | 23,009 | 26,000 | 23,009 | |
Feb 27 2017 | MDVX | Medovex Corp. | Moon Dennis Glenn | EXECUTIVE VICE PRES ... | Option Exercise | A | 1.13 | 35,575 | 40,200 | 35,575 | |
Feb 22 2017 | MDVX | Medovex Corp. | GORLIN STEVE | Option Exercise | P | 3.00 | 19,179 | 57,537 | 79,179 | ||
Feb 22 2017 | MDVX | Medovex Corp. | GORLIN STEVE | Option Exercise | P | 3.00 | 60,000 | 180,000 | 60,000 | ||
Feb 14 2017 | MDVX | Medovex Corp. | Gorlin Jarrett S | CHIEF EXECUTIVE OFF ... | Option Exercise | P | 1.50 | 33,654 | 50,481 | 95,968 | |
Feb 14 2017 | MDVX | Medovex Corp. | Gorlin Jarrett S | CHIEF EXECUTIVE OFF ... | Buy | P | 1.04 | 67,307 | 69,999 | 617,172 | 549.9 K to 617.2 K (+12.24 %) |
Feb 14 2017 | MDVX | Medovex Corp. | GORLIN STEVE | Option Exercise | P | 1.50 | 72,115 | 108,173 | 459,615 | ||
Feb 14 2017 | MDVX | Medovex Corp. | GORLIN STEVE | Buy | P | 1.04 | 144,230 | 149,999 | 1,340,020 | 1.2 M to 1.3 M (+12.06 %) | |
Jan 20 2017 | MDVX | Medovex Corp. | PAPASAN LARRY W | Grant | A | 1.38 | 21,739 | 30,000 | 217,815 | 196.1 K to 217.8 K (+11.09 %) | |
Jan 17 2017 | MDVX | Medovex Corp. | Thomas John C | Grant | A | 1.38 | 21,739 | 30,000 | 97,139 | 75.4 K to 97.1 K (+28.83 %) | |
Jan 17 2017 | MDVX | Medovex Corp. | Haufe Scott | Grant | A | 1.38 | 21,739 | 30,000 | 826,847 | 805.1 K to 826.8 K (+2.70 %) | |
Jan 17 2017 | MDVX | Medovex Corp. | Hennies Clyde A. | Grant | A | 1.38 | 21,739 | 30,000 | 121,027 | 99.3 K to 121 K (+21.89 %) | |
Jan 17 2017 | MDVX | Medovex Corp. | Mogford Jon | Grant | A | 1.38 | 3,019 | 4,166 | 3,019 | 0 to 3 K | |
Jan 17 2017 | MDVX | Medovex Corp. | Lawson James Ronald JR | Grant | A | 1.38 | 5,435 | 7,500 | 5,435 | 0 to 5.4 K | |
Jan 17 2017 | MDVX | Medovex Corp. | ANDREWS JAMES R M D | Grant | A | 1.38 | 21,739 | 30,000 | 121,027 | 99.3 K to 121 K (+21.89 %) | |
Jan 17 2017 | MDVX | Medovex Corp. | Betz Randal R | Grant | A | 1.38 | 21,739 | 30,000 | 141,027 | 119.3 K to 141 K (+18.22 %) | |
Dec 06 2016 | MDVX | Medovex Corp. | GORLIN STEVE | Option Exercise | P | 1.85 | 112,500 | 208,125 | 387,500 | ||
Dec 06 2016 | MDVX | Medovex Corp. | GORLIN STEVE | Buy | P | 1.75 | 314,286 | 550,001 | 1,018,592 | 704.3 K to 1 M (+44.62 %) | |
Dec 06 2016 | MDVX | Medovex Corp. | GORLIN STEVE | Sell | P | 1.75 | 257,143 | 450,000 | 704,360 | 961.5 K to 704.4 K (-26.74 %) | |
Feb 18 2016 | MDVX | Medovex Corp. | GORLIN STEVE | Buy | P | 1.81 | 552,041 | 999,967 | 961,503 | 409.5 K to 961.5 K (+134.82 %) | |
Apr 21 2016 | MDVX | Medovex Corp. | Gorlin Jarrett S | CHIEF EXECUTIVE OFF ... | Option Exercise | P | 1.30 | 22,040 | 28,652 | 62,840 | |
Apr 21 2016 | MDVX | Medovex Corp. | Gorlin Jarrett S | CHIEF EXECUTIVE OFF ... | Buy | P | 1.23 | 44,081 | 53,999 | 561,118 | 517 K to 561.1 K (+8.53 %) |
Jan 08 2016 | MDVX | Medovex Corp. | Wright Jeffery Scott | CHIEF FINANCIAL OFF ... | Option Exercise | A | 0.95 | 19,500 | 18,525 | 69,500 | |
Jan 08 2016 | MDVX | Medovex Corp. | Gorlin Jarrett S | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 0.95 | 40,800 | 38,760 | 40,800 | |
Jan 08 2016 | MDVX | Medovex Corp. | Moon Dennis Glenn | EXECUTIVE VICE PRES ... | Option Exercise | A | 0.95 | 30,150 | 28,643 | 45,150 | |
Jan 08 2016 | MDVX | Medovex Corp. | Sablowski Manfred | VP OF SALES AND MAR ... | Option Exercise | A | 0.95 | 22,500 | 21,375 | 122,500 | |
Jan 08 2016 | MDVX | Medovex Corp. | Kullmann Patrick C | COO, PRESIDENT | Option Exercise | A | 0.95 | 34,650 | 32,918 | 69,650 | |
Dec 22 2015 | MDVX | Medovex Corp. | Betz Randal R | Buy | P | 1.25 | 20,000 | 25,000 | 119,288 | 99.3 K to 119.3 K (+20.14 %) | |
Dec 18 2015 | MDVX | Medovex Corp. | GORLIN STEVE | Buy | P | 1.09 | 20,000 | 21,750 | 409,462 | 389.5 K to 409.5 K (+5.14 %) | |
Dec 18 2015 | MDVX | Medovex Corp. | GORLIN STEVE | Buy | P | 1.15 | 20,000 | 22,918 | 389,462 | 369.5 K to 389.5 K (+5.41 %) | |
Dec 16 2015 | MDVX | Medovex Corp. | Kullmann Patrick C | COO, PRESIDENT | Buy | P | 1.09 | 4,500 | 4,905 | 247,019 | 242.5 K to 247 K (+1.86 %) |
Nov 30 2015 | MDVX | Medovex Corp. | GORLIN STEVE | Option Exercise | P | 2.20 | 500,000 | 1,100,000 | 0 | ||
Nov 30 2015 | MDVX | Medovex Corp. | GORLIN STEVE | Option Exercise | P | 0.00 | 1 | 0 | 1 | ||
Nov 30 2015 | MDVX | Medovex Corp. | GORLIN STEVE | Buy | P | 1.45 | 40,000 | 57,960 | 369,462 | 329.5 K to 369.5 K (+12.14 %) | |
Nov 25 2015 | MDVX | Medovex Corp. | Hills Thomas Edward | Buy | P | 1.40 | 10,000 | 13,990 | 111,788 | 101.8 K to 111.8 K (+9.82 %) | |
Nov 25 2015 | MDVX | Medovex Corp. | Haufe Scott | Buy | P | 1.35 | 5,000 | 6,750 | 805,108 | 800.1 K to 805.1 K (+0.62 %) | |
Aug 13 2015 | MDVX | Medovex Corp. | Sablowski Manfred | SENIOR VICE PRESIDE ... | Option Exercise | A | 2.91 | 50,000 | 145,500 | 100,000 | |
Jun 24 2015 | MDVX | Medovex Corp. | Kullmann Patrick C | COO, PRESIDENT | Grant | A | 3.25 | 3,000 | 9,750 | 242,519 | 239.5 K to 242.5 K (+1.25 %) |
Jun 24 2015 | MDVX | Medovex Corp. | Haufe Scott | Grant | A | 3.25 | 25,000 | 81,250 | 800,108 | 775.1 K to 800.1 K (+3.23 %) | |
Jun 23 2015 | MDVX | Medovex Corp. | Sablowski Manfred | SENIOR VICE PRESIDE ... | Grant | A | 3.25 | 4,600 | 14,950 | 17,100 | 12.5 K to 17.1 K (+36.80 %) |
Jun 03 2015 | MDVX | Medovex Corp. | Kullmann Patrick C | PRESIDENT AND COO | Option Exercise | A | 3.61 | 35,000 | 126,350 | 35,000 | |
Jun 02 2015 | MDVX | Medovex Corp. | Moon Dennis Glenn | EXECUTIVE VICE PRES ... | Option Exercise | A | 3.61 | 15,000 | 54,150 | 15,000 |
Page: 1